NDC 72359-001

RETHYMIC

Allogenic Thymocyte-depleted Thymus Tissue-agdc

RETHYMIC is a Intramuscular Implant in the Human Prescription Drug category. It is labeled and distributed by Enzyvant Therapeutics Inc.. The primary component is Allogenic Thymocyte-depleted Thymus Tissue-agdc.

• Product ID: 72359-001_8cba898b-a93e-4df5-b541-95142ac58883
• NDC: 72359-001
• Product Type: Human Prescription Drug
• Proprietary Name: RETHYMIC
• Generic Name: Allogenic Thymocyte-depleted Thymus Tissue-agdc
• Dosage Form: Implant
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2021-10-08
• Marketing Category: BLA /
• Application Number: BLA125685
• Labeler Name: Enzyvant Therapeutics Inc.
• Substance Name: ALLOGENIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC
• Active Ingredient Strength: 22000 mm/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 72359-001-01

11 CONTAINER in 1 BOX (72359-001-01) > 4 IMPLANT in 1 CONTAINER

• Marketing Start Date: 2021-10-08
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details